Holen Sie sich die Stockscreener-App
3.38
0.30%
0.02
Handel nachbörslich:
3.37
-0.010
-0.30%
Schlusskurs vom Vortag:
$3.36
Offen:
$3.48
24-Stunden-Volumen:
22,350
Relative Volume:
0.43
Marktkapitalisierung:
$50.56M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.6301
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
-5.34%
1M Leistung:
-2.03%
6M Leistung:
-19.57%
1J Leistung:
+157.25%
1-Tages-Spanne:
$3.29
$3.48
1-Wochen-Bereich:
$3.29
$3.6884
52-Wochen-Spanne:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Vergleichen Sie CPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.38 | 50.27M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
143.46 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.81 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.12 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.61 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
Is Cumberland Pharmaceuticals Inc. a candidate for recovery playWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
How to build a dashboard for Cumberland Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - Stock Titan
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidanceQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Can volume confirm reversal in Cumberland Pharmaceuticals Inc.Chart Signals & Precise Entry and Exit Recommendations - newser.com
What the charts say about Cumberland Pharmaceuticals Inc. today2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. still worth holding after the dipMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com
Why Cumberland Pharmaceuticals Inc. stock is recommended by analystsEarnings Miss & Smart Allocation Stock Reports - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX) - MarketBeat
How to manage a losing position in Cumberland Pharmaceuticals Inc.Trade Volume Report & Low Risk Profit Maximizing Plans - newser.com
Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S No Reason For Excitement - simplywall.st
Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight - GlobeNewswire Inc.
Published on: 2025-10-06 05:25:30 - newser.com
Will Cumberland Pharmaceuticals Inc. benefit from macro trendsTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-10-06 02:33:45 - newser.com
Should you wait for a breakout in Cumberland Pharmaceuticals Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Sentiment analysis tools applied to Cumberland Pharmaceuticals Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Tick level data insight on Cumberland Pharmaceuticals Inc. volatilityWatch List & High Accuracy Swing Entry Alerts - newser.com
Cumberland Pharmaceuticals Announces Product Approval in Mexico - MarketScreener
Cumberland’s injectable ibuprofen receives approval in Mexico By Investing.com - Investing.com South Africa
Cumberland’s injectable ibuprofen receives approval in Mexico - Investing.com India
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO - WV News
Revolutionary Drug-Resistant Bacteria Fighter: Tabuk Brings Vibativ Antibiotic to Saudi Healthcare System - Stock Titan
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA - Sahm
Is Cumberland Pharmaceuticals Inc a good long term investmentEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in
What analysts say about Cumberland Pharmaceuticals Inc stockTechnical Analysis Insights & Reinvest for Maximum Compounding Returns - earlytimes.in
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):